SCHEMBL13024326

SCHEMBL13024326

CC(C)c1noc(CN2CC(Oc3ccc(-c4ccc(C(=O)N5CCCC5)c(F)c4)nc3)C2)n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 6/20 0.39
ALDH1A1 P00352 2/20 0.39
NPSR1 Q6W5P4 1/20 0.39
GPR183 P32249 1/20 0.37
MET P08581 2/20 0.36
CPS1 P31327 1/20 0.36
ATR Q13535 2/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
LMNA P02545 1/20 0.36
TSHR P16473 1/20 0.36
HTT P42858 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
MLNR O43193 1/20 0.35
CYP3A4 P08684 1/20 0.35
KCNH2 Q12809 1/20 0.35
MCHR1 Q99705 1/20 0.35
NR3C1 P04150 1/20 0.35
GRM2 Q14416 1/20 0.35
STAT3 P40763 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13024325 0.93 GPR119 (0.38) GPR119ALDH1A1NPSR1GPR183CPS1
SCHEMBL2891413 0.92 GPR119 (0.37) GPR119ALDH1A1GPR183MEN1KMT2A
SCHEMBL13024281 0.90 GPR119 (0.39) GPR119GPR183KCNH2MCHR1GRM2
SCHEMBL2891859 0.90 HDAC4 (0.39) GPR119GPR183MET
SCHEMBL2904085 0.89 GRM2 (0.40) GPR119GPR183METGRM2
SCHEMBL2893546 0.89 GPR119 (0.38) GPR119GPR183KCNH2MCHR1GRM2
SCHEMBL2893540 0.89 GPR119 (0.38) GPR119GPR183KCNH2GRM2STAT3
SCHEMBL2891626 0.87 GPR119 (0.38) GPR119ALDH1A1GPR183MEN1KMT2A
SCHEMBL2894005 0.87 MTOR (0.40) GPR119GPR183METGRM2
SCHEMBL2888036 0.85 HDAC4 (0.44) GPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100286110-A1 AZETIDINYL G-PROTEIN COUPLED RECEPTOR AGONISTS PROSIDION LIMITED (GB) 2010-11-11 US disclosed
US-20100286110-A1 AZETIDINYL G-PROTEIN COUPLED RECEPTOR AGONISTS PROSIDION LIMITED (GB) 2010-11-11 US disclosed
WO-2009050523-A1 AZETIDINYL G-PROTEIN COUPLED RECEPTOR AGONISTS PROSIDION LIMITED (GB) 2009-04-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100286110-A1 AZETIDINYL G-PROTEIN COUPLED RECEPTOR AGONISTS GPR119, GIPR, GPR39 GPR119 1/4885ALDH1A1 1738/4885NPSR1 97/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.